SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-037897
Filing Date
2024-03-22
Accepted
2024-03-22 16:31:10
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 tm249132-1_s3.htm S-3 419359
2 EXHIBIT 5.1 tm249132d2_ex5-1.htm EX-5.1 26325
3 EXHIBIT 23.1 tm249132d2_ex23-1.htm EX-23.1 2662
4 EX-FILING FEES tm249132d2_ex-filingfees.htm EX-FILING FEES 10634
5 GRAPHIC lg_appliedtherapeutics-4c.jpg GRAPHIC 35516
  Complete submission text file 0001104659-24-037897.txt   508438
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278182 | Film No.: 24775720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)